RedChip Highlights Public Companies Advancing the Next Phase of AI Adoption at Virtual Investor Conference on March 19 [Yahoo! Finance]
Lantern Pharma Inc. (LTRN)
Company Research
Source: Yahoo! Finance
ORLANDO, FL / ACCESS Newswire / March 16, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming AI Investor Conference: From Data Centers to Breakthrough Use Cases , taking place March 19, 2026, from 9:30 a.m. to 4:00 p.m. ET. The full-day virtual event will spotlight publicly traded companies developing, enabling, and deploying artificial intelligence technologies across infrastructure, analytics, automation, and applied industry solutions, offering investors direct access to management teams driving innovation across the AI value chain. Registration is free and open to the public: https://www.redchip.com/webinar/redchip/87020434458 "Artificial intelligence is rapidly transforming how data is processed, decisions are made, and products are delivered across the global economy," said Dave Gentry, CEO of RedChip Companies. "From the data centers and compute platforms powering AI wor
Show less
Read more
Impact Snapshot
Event Time:
LTRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LTRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LTRN alerts
High impacting Lantern Pharma Inc. news events
Weekly update
A roundup of the hottest topics
LTRN
News
- Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition [Yahoo! Finance]Yahoo! Finance
- Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026Business Wire
- Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue SarcomasBusiness Wire
- Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies [Yahoo! Finance]Yahoo! Finance
- Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma CompaniesBusiness Wire
LTRN
Earnings
- 8/13/25 - Beat
LTRN
Sec Filings
- 2/23/26 - Form SCHEDULE
- 1/23/26 - Form 8-K
- 1/13/26 - Form 4
- LTRN's page on the SEC website